---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-024156"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:40:59.256236+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech raises $2.5M via unsecured promissory note with Streeterville Capital

## Summary
- Net proceeds of $2,500,000 from $3,301,250 note after $781,250 OID and $20,000 transaction costs.
- Note bears 10% interest compounded daily, matures in 24 months from November 18, 2025.
- Investor may redeem up to $250,000 per month starting 6 months after closing.
- Mandatory prepayment of 12.5% of any future financing proceeds until note is paid.
- Note is unsecured; events of default include cross-default and bankruptcy provisions.

## SEC filing metadata
- accession: 0001493152-25-024156
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315225024156/0001493152-25-024156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315225024156/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-024156
- JSON: https://secwatch.observer/filing/0001493152-25-024156.json
- Plain text: https://secwatch.observer/filing/0001493152-25-024156.txt

## Key facts
- Debt Financings
  AIM ImmunoTech Inc. incurred loan of $3,301,250 with Streeterville Capital, LLC at ten percent (10%) per annum compounded daily maturing 24 months from the date of its issuance.
  - Instrument: loan
  - Principal: $3,301,250
  - Counterparty: Streeterville Capital, LLC
  - Rate: ten percent (10%) per annum compounded daily
  - Maturity: 24 months from the date of its issuance
  - Event: incurrence
  source text: On November 18, 2025, AIM ImmunoTech Inc. (the “Company”, “we”, “us” or “our”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”) with Streeterville Capital, LLC (the “ Investor ”) and consummated the sale to such Investor of an unsecured Promissory Note (the “ Note ”) with an original principal amount of $3,301,250 in a private placement (the “ Private Placement ”) that closed on November 18, 2025. The Note carries an original issuance discount of $781,250 and the Company agreed to pay $20,000 to the Investor to cover the Investor’s legal and administrative transaction costs, each of which were included in the original principal amount and deducted from the proceeds of the Note received by the Company which resulted in a purchase price received by the Company of $2,500,000. The Note bears interest at ten percent (10%) per annum compounded daily. The maturity date of the Note is 24 months from the date of its issuance (the “ Maturity Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315225024156/0001493152-25-024156-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.